Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial
Weiss, J.M., Csoszi, T., Maglakelidze, M., Hoyer, R.J., Beck, J.T., Domine Gomez, M., Lowczak, A., Aljumaily, R., Rocha Lima, C.M., Boccia, R.V., Hanna, W., Nikolinakos, P., Chiu, V.K., Owonikoko, T.K., Schuster, S.R., Hussein, M.A., Richards, D.A., Sawrycki, P., Bulat, I., Hamm, J.T., Hart, L.L., Adler, S., Antal, J.M., Lai, A.Y., Sorrentino, J.A., Yang, Z., Malik, R.K., Morris, S.R., Roberts, P.J., Dragnev, K.H.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2
Rugo, H.S., Pritchard, K.I., Gnant, M., Noguchi, S., Piccart, M., Hortobagyi, G., Baselga, J., Perez, A., Geberth, M., Csoszi, T., Chouinard, E., Srimuninnimit, V., Puttawibul, P., Eakle, J., Feng, W., Bauly, H., El-Hashimy, M., Taran, T., Burris, H.A.
Published in Annals of oncology (01.04.2014)
Published in Annals of oncology (01.04.2014)
Get full text
Journal Article
Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)
Ruzsa, A., Sen, M., Evans, M., Lee, L. W., Hideghety, K., Rottey, S., Klimak, P., Holeckova, P., Fayette, J., Csoszi, T., Erfan, J., Forssmann, U., Goddemeier, T., Bexon, A., Nutting, C.
Published in Investigational new drugs (01.12.2014)
Published in Investigational new drugs (01.12.2014)
Get full text
Journal Article
A phase II study of retifanlimab, a humanized anti-PD-1 monoclonal antibody, in patients with solid tumors (POD1UM-203)
Di Giacomo, A.M., Schenker, M., Medioni, J., Mandziuk, S., Majem, M., Gravis, G., Cornfeld, M., Ranganathan, S., Lou, S., Csoszi, T.
Published in ESMO open (01.03.2024)
Published in ESMO open (01.03.2024)
Get full text
Journal Article
Trilaciclib (T) decreases multi-lineage myelosuppression in extensive-stage small cell lung cancer (ES-SCLC) patients receiving first-line chemotherapy
Dragnev, K.H., Owonikoko, T.K., Csoszi, T., Maglakelidze, M., Beck, J.T., Domine Gomez, M., Lowczak, A., Fulop, A., Hoyer, R.J., Hanna, W., Lowry, P., Aljumaily, R., Chiu, V.K., Bulat, I., Yang, Z., Roberts, P.J., Antal, J.M., Malik, R.K., Morris, S.R., Weiss, J.M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
Paz-Ares, Luis, Luft, Alexander, Vicente, David, Tafreshi, Ali, Gümüş, Mahmut, Mazières, Julien, Hermes, Barbara, Çay Şenler, Filiz, Csőszi, Tibor, Fülöp, Andrea, Rodríguez-Cid, Jerónimo, Wilson, Jonathan, Sugawara, Shunichi, Kato, Terufumi, Lee, Ki Hyeong, Cheng, Ying, Novello, Silvia, Halmos, Balazs, Li, Xiaodong, Lubiniecki, Gregory M, Piperdi, Bilal, Kowalski, Dariusz M
Published in The New England journal of medicine (22.11.2018)
Published in The New England journal of medicine (22.11.2018)
Get full text
Journal Article
Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial—PEARL
Martin, M., Zielinski, C., Ruiz-Borrego, M., Carrasco, E., Turner, N., Ciruelos, E.M., Muñoz, M., Bermejo, B., Margeli, M., Anton, A., Kahan, Z., Csöszi, T., Casas, M.I., Murillo, L., Morales, S., Alba, E., Gal-Yam, E., Guerrero-Zotano, A., Calvo, L., de la Haba-Rodriguez, J., Ramos, M., Alvarez, I., Garcia-Palomo, A., Huang Bartlett, C., Koehler, M., Caballero, R., Corsaro, M., Huang, X., Garcia-Sáenz, J.A., Chacón, J.I., Swift, C., Thallinger, C., Gil-Gil, M.
Published in Annals of oncology (01.04.2021)
Published in Annals of oncology (01.04.2021)
Get full text
Journal Article
Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial
Élez, E., Kocáková, I., Höhler, T., Martens, U.M., Bokemeyer, C., Van Cutsem, E., Melichar, B., Smakal, M., Csőszi, T., Topuzov, E., Orlova, R., Tjulandin, S., Rivera, F., Straub, J., Bruns, R., Quaratino, S., Tabernero, J.
Published in Annals of oncology (01.01.2015)
Published in Annals of oncology (01.01.2015)
Get full text
Journal Article
Population Pharmacokinetics of Liposomal Irinotecan in Patients With Cancer
Adiwijaya, BS, Kim, J, Lang, I, Csõszi, T, Cubillo, A, Chen, J‐S, Wong, M, Park, JO, Kim, JS, Rau, KM, Melichar, B, Gallego, JB, Fitzgerald, J, Belanger, B, Molnar, I, Ma, WW
Published in Clinical pharmacology and therapeutics (01.12.2017)
Published in Clinical pharmacology and therapeutics (01.12.2017)
Get full text
Journal Article
OA01.04 IMpower010 5-y Subgroup Analysis and Relapse Patterns: Phase 3 Study of Atezolizumab vs BSC in Stage II-IIIA NSCLC
Felip, E., Wakelee, H.A., Vallieres, E., Martinez-Marti, A., Goloborodko, O., Zhou, C., Rittmeyer, A., Chella, A., Reck, M., Csoszi, T., Bondarenko, I., Kenmotsu, H., Schutte, W., Ding, B., Zhu, Q., Ballinger, M., Bennett, E., Gitlitz, B.J., Altorki, N.
Published in Journal of thoracic oncology (01.10.2024)
Published in Journal of thoracic oncology (01.10.2024)
Get full text
Journal Article
VP11-2021: Trifluridine/tipiracil plus bevacizumab vs capecitabine plus bevacizumab as first line treatment for patients with metastatic colorectal cancer (mCRC) ineligible for intensive therapy: The phase III randomized SOLSTICE study
André, T., Falcone, A., Shparyk, Y., Moiseenko, F.V., Marques, E. Polo, Csoszi, T., Bragagnoli, A. Campos, Liposits, G., Chmielowska, E., Aubel, P., Martín-Fernández, L., Fougeray, R., Causse-Amellal, N., Saunders, M.P.
Published in Annals of oncology (01.02.2022)
Published in Annals of oncology (01.02.2022)
Get full text
Journal Article
2365 Nanoliposomal irinotecan (MM-398, nal-IRI) population pharmacokinetics (PK) and its association with efficacy and safety in patients with solid tumors based on the phase 3 study NAPOLI-1 and five phase 1 and 2 studies
Ma, W.W, Chung, I, Lang, I, Csõszi, T, Wenczl, M.W, Cubillo, A, Chen, J, Wong, M, Park, J.O, Kim, J.S, Rau, K.M, Melichar, B, Gallego, J, Smakal, M, Kim, J, Belanger, B, Bayever, E, Adiwijaya, B
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
1752P Post hoc analysis of pembrolizumab efficacy in potentially platinum ineligible patients with urothelial carcinoma enrolled in KEYNOTE-052 and LEAP-011
Loriot, Y., Csoszi, T., Matsubara, N., Shin, S.J., Park, S.H., Atduev, V., Gumus, M., Karaca, B.B., Grivas, P., De Wit, R., Siefker-Radtke, A.O., Castellano Gauna, D.E., O'Donnell, P.H., Powles, T.B., Vuky, J., Zhao, Y., O'hara, K., Franco, S., Homet Moreno, B., Zolnierek, J.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
229MO Overall survival (OS) of palbociclib (P) plus endocrine therapy (ET) versus capecitabine (CAP) in hormone-receptor+/HER2- metastatic breast cancer (MBC) that progressed on aromatase inhibitors (AIs): Final results of the PEARL study
Martin Jimenez, M., Zielinski, C., Ruiz-Borrego, M., Carrasco, E., Ciruelos, E.M., Muñoz, M., Bermejo, B., Margeli, M., Csoszi, T., Anton, A., Turner, N., Casas, M.I., Morales, S., Alba, E., Calvo, L., De La Haba, J., Ramos, M., Corsaro, M., Kahan, Z., Gil-Gil, M.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
TRYbeCA-2: A randomized phase II/III study of eryaspase in combination with gemcitabine and carboplatin chemotherapy versus chemotherapy alone as first-line treatment in patients with metastatic or locally recurrent triple-negative breast cancer
Awada, A.H., Cortés, J., Slater, S., Macpherson, I., Csoszi, T., Bertrand, J.-B., Clermont, A.-S., Pollard, R., Chrestia-Blanchine, R., Biswas-Baldwin, N., Youssoufian, H., El-Hariry, I.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
381TiPTRYbeCA-2: A randomized phase II/III study of eryaspase in combination with gemcitabine and carboplatin chemotherapy versus chemotherapy alone as first-line treatment in patients with metastatic or locally recurrent triple-negative breast cancer
Awada, A H, Cortés, J, Slater, S, Macpherson, I, Csoszi, T, Bertrand, J -B, Clermont, A -S, Pollard, R, Chrestia-Blanchine, R, Biswas-Baldwin, N, Youssoufian, H, El-Hariry, I
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
381TiP - TRYbeCA-2: A randomized phase II/III study of eryaspase in combination with gemcitabine and carboplatin chemotherapy versus chemotherapy alone as first-line treatment in patients with metastatic or locally recurrent triple-negative breast cancer
Awada, A.H., Cortés, J., Slater, S., Macpherson, I., Csoszi, T., Bertrand, J.-B., Clermont, A.-S., Pollard, R., Chrestia-Blanchine, R., Biswas-Baldwin, N., Youssoufian, H., El-Hariry, I.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Randomized phase 2 study of investigational aurora A kinase (AAK) inhibitor alisertib (MLN8237) + paclitaxel (P) vs placebo + P as second line therapy for small-cell lung cancer (SCLC)
Owonikoko, T.K., Nackaerts, K., Csoszi, T., Ostoros, G., Baik, C., Mark, Z., Sheldon-Waniga, E., Huebner, D., Leonard, E.J., Spigel, D.R.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
1666PDTrilaciclib (T) decreases multi-lineage myelosuppression in extensive-stage small cell lung cancer (ES-SCLC) patients receiving first-line chemotherapy
Dragnev, K H, Owonikoko, T K, Csoszi, T, Maglakelidze, M, Beck, J T, Domine Gomez, M, Lowczak, A, Fulop, A, Hoyer, R J, Hanna, W, Lowry, P, Aljumaily, R, Chiu, V K, Bulat, I, Yang, Z, Roberts, P J, Antal, J M, Malik, R K, Morris, S R, Weiss, J M
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Randomized, Double-Blind, Placebo-Controlled Trial of Evofosfamide (TH-302) in Combination with Pemetrexed in Advanced Non-Squamous Non-Small Cell Lung Cancer
Goldman, J., Belani, C., Novello, S., von Pawel, J., Csoszi, T., Orlov, S., Kroll, S., Pearce, T.
Published in Annals of oncology (01.04.2015)
Published in Annals of oncology (01.04.2015)
Get full text
Journal Article